Replies to post #137356 on Biotech Values

[genisi]

Since ribavirin's MoA is often compared to a weak purine nucleotide, do you feel this class could make up for the shortcomings of the GS-7977/Riba combination in nulls?

Yes, but I think a potent agent from another class could also do that.